Multipotent adult progenitor cell isolation and proliferation in cytokine and serum-free medium conditioned by rat B104 cells
- PMID: 19961484
- DOI: 10.1111/j.1365-2141.2009.07986.x
Multipotent adult progenitor cell isolation and proliferation in cytokine and serum-free medium conditioned by rat B104 cells
Abstract
This report describes the isolation of rodent multipotent adult progenitor cells (MAPCs) and proliferation of these cells in both standard medium and medium without exogenous serum or growth factors conditioned by the rat cell line B104. MAPCs have exacting requirements for their proliferation in vitro but once established proliferate rapidly at low seeding density, requiring almost daily passage and media exchange. Previously published methods for growth of MAPCs in vitro all used media supplemented with serum and growth factors, which adds considerable expense.
Similar articles
-
Multipotent adult progenitor cell isolation and culture procedures.Exp Hematol. 2006 Nov;34(11):1596-601. doi: 10.1016/j.exphem.2006.07.013. Exp Hematol. 2006. PMID: 17046581
-
Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.Biotechnol Prog. 2005 Jan-Feb;21(1):87-95. doi: 10.1021/bp049822g. Biotechnol Prog. 2005. PMID: 15903244
-
Clonal proliferation of multipotent stem/progenitor cells in the neonatal and adult salivary glands.Biochem Biophys Res Commun. 2006 Feb 10;340(2):544-52. doi: 10.1016/j.bbrc.2005.12.031. Epub 2005 Dec 19. Biochem Biophys Res Commun. 2006. PMID: 16376857
-
Large-scale generation of highly enriched neural stem-cell-derived oligodendroglial cultures: maturation-dependent differences in insulin-like growth factor-mediated signal transduction.J Neurochem. 2007 Feb;100(3):628-38. doi: 10.1111/j.1471-4159.2006.04171.x. J Neurochem. 2007. PMID: 17263792
-
Multipotent adult progenitor cells: an update.Novartis Found Symp. 2005;265:55-61; discussion 61-5, 92-7. Novartis Found Symp. 2005. PMID: 16050250 Review.
Cited by
-
Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.Trials. 2015 Oct 14;16:463. doi: 10.1186/s13063-015-0953-1. Trials. 2015. PMID: 26467901 Free PMC article. Clinical Trial.
-
Histone Arginine Methylation-Mediated Epigenetic Regulation of Discoidin Domain Receptor 2 Controls the Senescence of Human Bone Marrow Mesenchymal Stem Cells.Stem Cells Int. 2019 Jul 11;2019:7670316. doi: 10.1155/2019/7670316. eCollection 2019. Stem Cells Int. 2019. PMID: 31379950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources